Boibessot, Clovis
Joncas, France-Hélène
Park, Aerin
Berrehail, Zohra
Pelletier, Jean-François
Gris, Typhaine
Bergeron, Alain
Toren, Paul
Funding for this research was provided by:
Cancer Research Society (23483)
Canadian Urological Oncology Group
Fonds de Recherche du Québec - Santé (32774)
Article History
Received: 27 October 2020
Accepted: 9 September 2021
First Online: 29 September 2021
Competing interests
: AB reports research funding from Astellas, IMV Inc, GSK biologicals as well as personal fees as a consultant from Merck. PT reports research funding from Bristol-Myers-Squibb, Sanofi and Janssen as well as personal fees as a consultant from TerSera, Janssen, Sanofi, Ferring and Abbvie. The other authors have no conflicts of interest to declare.